drugset / Trial / NCT01148420

DMPA & High Dose Oral Progestin (MPA) Tablets in Outpatient Treatment of Acute Excessive Vaginal Bleeding

NCT01148420

Phase 4 Completed 48 enrolled Women's Health Care Clinic, Torrance, California
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the effectiveness and acceptability of high dose MPA (20mg oral 3 times a day) for 3 days combined with an injection of DMPA 150 mg intramuscularly in the treatment of acute heavy, prolonged uterine bleeding who have been identified as being eligible for outpatient management

Timeline

Start
2009-01
Primary completion
2010-10
Completion
2012-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject medroxyprogesterone acetate Other / unclassified 20 mg Oral
Subject medroxyprogesterone acetate Other / unclassified 150 mg Oral

Indications